Ipsen Poland Sp. z o.o. is the Polish affiliate of Ipsen, operating in the innovative pharmaceutical sector with a mission focused on improving the quality of life of patients suffering from severe diseases through continuous search and development of innovative therapies. The companys therapeutic scope in Poland covers oncology, endocrinology and neurology, complemented by consumer healthcare activities, reflecting a portfolio positioned around specialist care and selected self-care categories. Ipsen Poland supports disease education and stakeholder engagement in its core therapeutic areas and cooperates with medical associations and foundations, reinforcing a multi-stakeholder model spanning clinicians, patient organizations and scientific communities. The geographic scope is Poland as a commercialization and medical engagement market, integrated into Ipsens international footprint and R&D-driven value chain. Key assets are the local product portfolio marketed in Poland, the specialist commercial and medical organization, and structured partnerships across the healthcare ecosystem. Strategically, Ipsen positions itself as an innovation-led company in specialty care, targeting growth and profitability ambitions at group level while prioritizing patient-centric innovation and high-impact therapies in clearly defined therapeutic domains.
Headquarters
Ul. Chmielna 73
Warsaw; Mazowieckie;
Postal Code: 00-801
Contact Details: Purchase the Ipsen Poland Sp. z o.o. report to view the information.
Website: http://www.ipsen.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service